LAKE OSWEGO, Ore., April 26, 2022 /PRNewswire/ -- BIOTRONIK, Inc. announced today it has received U.S. Food and Drug Administration (FDA) approval of Renamic Neo, the company's state-of-the-art ...

Global manufacturer of cardiovascular medical devices BIOTRONIK announced the release of its Renamic product for the Japanese market. The announcement is in response to the dramatic growth of cardiac ...

LAKE OSWEGO, Ore. & BERLIN--(BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, announced today the US market ...

BERLIN--(BUSINESS WIRE)--BIOTRONIK SE & Co. KG announced today the European market launch of their new Renamic implantable cardiac device programmer. Renamic is the latest addition to BIOTRONIK’s new ...